Catherine Moukheibir - 15 Dec 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Dec 2023
Net transactions value
$0
Form type
4
Filing time
19 Dec 2023, 16:05:17 UTC
Previous filing
19 Sep 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +1,572 +1.2% $0.000000 128,633 15 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.